Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/16/2012CN102459189A 5-元杂环化合物环戊二烯并[c]吡咯基烷基氨基甲酸酯衍生物、其制备、及其治疗用途 5-membered heterocyclic compound cyclopenta [c] pyrrolyl group carbamate derivatives, their preparation, and their therapeutic use
05/16/2012CN102459188A 新型6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂 Novel 6-aryl-amino-pyridone and 6-aryl sulfonamide amino pyrazinone sulfonamide inhibitors mek
05/16/2012CN102459187A Janus激酶抑制化合物和方法 Janus kinase inhibiting compounds and methods
05/16/2012CN102459186A 抗蠕虫剂和其应用 Anthelmintics and their applications
05/16/2012CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459181A 2′-{[2-(4-甲氧基-苯基)-乙酰基氨基]-甲基}-联苯基-2-甲酸(2-吡啶-3-基-乙基)-酰胺的晶相 2 '- {[2- (4-methoxy - phenyl) - acetylamino] - methyl} - biphenyl-2-carboxylic acid (2-pyridin-3-yl - ethyl) - amide crystalline phase
05/16/2012CN102459180A Urea derivatives as kinase inhibitors
05/16/2012CN102459179A Pyridinone antagonists of alpha-4 integrins
05/16/2012CN102459178A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102459177A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102459170A Crystal forms of saxagliptin
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459165A 抗病毒化合物 Antiviral compounds
05/16/2012CN102459162A 新型环戊烷衍生物 The new derivatives of cyclopentane
05/16/2012CN102459160A Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
05/16/2012CN102459159A 烷酰基氨基苯甲酰胺苯胺hdac抑制剂化合物 Alkanoylamino benzamide aniline hdac inhibitor compound
05/16/2012CN102459158A 新的酰胺和脒衍生物和其用途 Novel amide and amidine derivatives and use thereof
05/16/2012CN102459146A 制备苯并呋喃的方法 Method for preparing benzofuran
05/16/2012CN102459142A Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/16/2012CN102458581A N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
05/16/2012CN102458580A 作为mek抑制剂的杂环化合物 As a heterocyclic compound mek inhibitor
05/16/2012CN102458475A Dry-coated orally-disintegrating tablet
05/16/2012CN102458466A 使用抗-egfr剂和igf-1r特异性的抑制剂的组合治疗 Using a combination of therapeutic agents and anti--egfr igf-1r specific inhibitors
05/16/2012CN102458435A 认知衰退的抑制剂 Cognitive decline inhibitors
05/16/2012CN102458422A Rna virus infection inhibitor, method for inhibition of infection by rna virus, products for inhibition of infection by rna virus, and use as rna virus infection inhibitor
05/16/2012CN102458421A Medicinal agent
05/16/2012CN102458420A Lipid-polymer conjugates, their preparation and uses thereof
05/16/2012CN102458419A Use of a composition for the treatment of mucositis
05/16/2012CN102458418A Methods for treating chronic kidney disease
05/16/2012CN102458417A Enhancer of activity of nucleic acid analogue
05/16/2012CN102458416A Interlaced method for treating cancer or a precancerous condition
05/16/2012CN102458415A Bifidobacteria for treating diabetes and related conditions
05/16/2012CN102458414A Use of toosendanin or melia azedarach extracts for preventing or treating dementia
05/16/2012CN102458413A Method and composition for treating macular degeneration
05/16/2012CN102458412A Pyrazolopyrimidines and related heterocycles as kinase inhibitors
05/16/2012CN102458411A 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
05/16/2012CN102458410A Methods of treatment for solid tumors
05/16/2012CN102458409A Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
05/16/2012CN102458408A Inhibitors of influenza viruses replication
05/16/2012CN102458407A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
05/16/2012CN102458406A Oral liquid preparation
05/16/2012CN102458405A Novel anti-inflammatory agents
05/16/2012CN102458404A Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
05/16/2012CN102458403A Pesticidal compositions
05/16/2012CN102458402A Nicotinamide compounds useful as kinase modulators
05/16/2012CN102458401A Therapeutic agent for hypertension or normal high blood pressure
05/16/2012CN102458400A Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
05/16/2012CN102458399A Novel therapeutic treatments using centhaquin
05/16/2012CN102458398A Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
05/16/2012CN102458397A Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
05/16/2012CN102458396A Stabilization of radiopharmaceutical compositions using ascorbic acid
05/16/2012CN102458395A Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102458393A 治疗肺结核的组合物 Therapeutic composition tuberculosis
05/16/2012CN102458392A Antitumor combination including cabazitaxel and capecitabine
05/16/2012CN102458391A Use of pufas for treating skin inflammation
05/16/2012CN102458390A Combination of leucine source and omega-3 unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia
05/16/2012CN102458389A Anti-inflammatory agents as virostatic compounds
05/16/2012CN102458388A Semi-solid compositions and pharmaceutical products
05/16/2012CN102458387A New compositions for treating cmt and related disorders
05/16/2012CN102458386A 用于紧急避孕的药物组合物 Pharmaceutical compositions for emergency contraception
05/16/2012CN102458385A Oral care method and kit
05/16/2012CN102458384A Stable topical compositions for 1,2,4-thiadiazole derivatives
05/16/2012CN102458383A Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
05/16/2012CN102458382A Oil-in-water emulsion of mometasone and propylene glycol
05/16/2012CN102458381A Coccidiosis control agent and feed containing same
05/16/2012CN102458375A Burst drug release compositions
05/16/2012CN102458373A Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
05/16/2012CN102458372A Agglomerate formulations useful in dry powder inhalers
05/16/2012CN102458369A Compositions and methods for drug delivery
05/16/2012CN102458368A Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
05/16/2012CN102458364A Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
05/16/2012CN102458363A Pharmaceutical oral telmisartan solution
05/16/2012CN102458362A Topical retinoid solutions
05/16/2012CN102458361A Lipid formulation of apoptosis promoter
05/16/2012CN102458358A Sublingual pharmaceutical composition comprising a neutral oil
05/16/2012CN102458351A Agent for preventing or treating abnormality in skin water permeation function
05/16/2012CN102458155A Green tea extracts of improved bioavailability
05/16/2012CN102458152A Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
05/16/2012CN102458127A 用于治疗多发性骨髓瘤的联合治疗 Combination therapy for the treatment of multiple myeloma
05/16/2012CN102458122A 含有哒嗪磺胺衍生物的化合物、组合物和方法 Compounds, compositions and methods of pyridazine derivatives containing sulfonamide
05/16/2012CN102458121A 使用4-甲基吡唑治疗人类个体的基因型特异性方法 4-methyl-pyrazol-genotype-specific treatment of a human subject method
05/16/2012CN102458117A 含有非阿片样和阿片样止痛药的组合的口腔崩解片组合物 Comprising a non-opioid and opioid analgesics orally disintegrating tablet combination compositions
05/16/2012CN102458116A Iap inhibitors
05/16/2012CN102458115A Iap inhibitors
05/16/2012CN102458113A 与缺血再灌注相关的水肿的治疗方法 Associated with ischemia-reperfusion edema treatment
05/16/2012CN102458112A Nanoparticle formulations and uses therof
05/16/2012CN102458110A Diffusion enhancing compounds and their use alone or with thrombolytics
05/16/2012CN102458109A Stable pharmaceutical composition and methods of using same
05/16/2012CN102453689A Lactobacillus plantarum strain producing extracellular polysaccharide, and application thereof
05/16/2012CN102453074A Pentacyclic triterpene saponin and application thereof
05/16/2012CN102453066A Compound molecule, and preparation method and pharmaceutical composition thereof
05/16/2012CN102453060A Ethyl salicylate glycosides and synthetic method and application thereof
05/16/2012CN102453050A Bisphosphonate compound and preparation method thereof
05/16/2012CN102453028A Antifungal agent 2-[(2,3-dihydro-4H-benzo-[b]thiapyran-4-ylidene) hydrazono]-4-oxotetrahydro thiazole (oxazole)-5-acetic acid derivative
05/16/2012CN102453026A C-aryl glucoside derivative, preparation method and application thereof
1 ... 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 ... 7860